BerandaIONS • NASDAQ
add
Ionis Pharmaceuticals Inc
$34,05
Setelah Jam Perdagangan Normal:(0,00%)0,00
$34,05
Tutup: 27 Jan, 16.20.00 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$34,75
Rentang hari
$33,72 - $35,31
Rentang tahun
$31,41 - $52,49
Kapitalisasi pasar
5,38 M USD
Volume Rata-Rata
1,56 jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 133,81 jt | -7,21% |
Biaya operasional | 259,28 jt | -2,73% |
Laba bersih | -140,48 jt | 4,70% |
Margin laba bersih | -104,98 | -2,70% |
Penghasilan per saham | -0,72 | 14,35% |
EBITDA | -145,68 jt | -3,99% |
Tarif pajak efektif | 2,51% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,49 M | 11,10% |
Total aset | 3,08 M | 5,01% |
Total liabilitas | 2,42 M | -7,63% |
Total ekuitas | 662,47 jt | — |
Saham yang beredar | 157,90 jt | — |
Harga terhadap nilai buku | 8,27 | — |
Tingkat pengembalian aset | -12,88% | — |
Tingkat pengembalian modal | -15,15% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -140,48 jt | 4,70% |
Kas dari operasi | -114,99 jt | -5,47% |
Kas dari investasi | -340,80 jt | -595,98% |
Kas dari pembiayaan | 496,05 jt | 1.637,32% |
Perubahan kas bersih | 40,61 jt | 155,84% |
Arus kas bebas | -46,15 jt | 46,55% |
Tentang
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. The company has three commercially approved medicines: Spinraza, Tegsedi, and Waylivra, and has four drugs in pivotal studies: tominersen for Huntington's disease, tofersen for SOD1-ALS, AKCEA-APO-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis.
The company was named Isis Pharmaceuticals until December 2015. Wikipedia
Didirikan
1989
Kantor pusat
Situs
Karyawan
927
